We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×

Synthesis, resolution, derivatization and antibacterial activity of chuangxinmycin

    Lianqi Sun

    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China

    ,
    Shuo Zhang

    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China

    ,
    Xinyue Hu

    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China

    ,
    Jie Jin

    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China

    &
    Zhuorong Li

    *Author for correspondence:

    E-mail Address: lizhuorong@imb.pumc.edu.cn

    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China

    Published Online:https://doi.org/10.4155/fmc-2019-0209

    Aim: An urgent need for the development of antibiotics with novel structures and unexploited targets. Materials & methods: Racemic chuangxinmycin was obtained via a novel synthesis route. Chiral preparative chromatography was used to separate chuangxinmycin from its epimers, and four stereoisomers were obtained. Fourteen derivatives were synthesized and their antibacterial activities were evaluated against Escherichia coli and Staphylococcus aureus. Results: Synthesized (3S, 4R)-chuangxinmycin showed antibacterial activity against S. aureus with minimum inhibitory concentration of 4–8 μg/ml (17.2–34.3 μM), which were consistent with the antibacterial activity of chuangxinmycin obtained by fermentation. The minimum inhibitory concentrations of other stereoscopic chuangxinmycin species and chuangxinmycin derivatives were >128 μg/ml. Conclusion: Results indicate that the antibacterial activity of chuangxinmycin is dependent on the stereoselectivity of structures, and that the electron cloud density and amphipathic properties of chuangxinmycin have little effect on its antibacterial activity.

    Graphical abstract

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Devasahaym G, Scheld WM, Hoffman PS. Newer antibacterial drugs for a new century. Expert Opin. Invest. Drugs 19, 215–234 (2010). • Very important report regarding the current situation of multidrug resistance.
    • 2. Projan SJ, Youngman PJ. Antimicrobials: new solutions badly need-editorial overview. Curr. Opin. Microbiol. 5(5), 463–465 (2002).
    • 3. Liang XT, Xu XD, Zhang ZP, Gu HE, Wang WX. Structural determination of chuangxinmycin. Hua Xue Xue Bao 34(2), 129–132 (1976); Chem. Abstr. 87, 165948z (1977); Sci. Sin. 20, 106 (1977); Chem. Abstr. 87, 98565g (1977).
    • 4. Xu XJ, Shao MC, Zhang ZY et al. The crystal structure of chuangmycin. Ke Xue Tong Bao 8, 350 (1980).
    • 5. Brown MJ, Carter PS, Fenwick AE et al. The antimicrobial natural product chuangxinmycin and some synthetic analogues are potent and selective inhibitors of bacterial tryptophanyl tRNA synthetase. Bioorg. Med. Chem. Lett. 12, 3171–3174 (2002). • Very important report regarding the structure–activity relationship of chuangxinmycin.
    • 6. Kozikowski AP, Greco MN. Total synthesis of the unique indole alkaloid chuangxinmycin. Application of nitro group displacement reactions in organic synthesis. J. Am. Chem. Soc. 102(3), 1165–1166 (1980).
    • 7. Kozikowski AP, Greco MN, Springer JP. Synthetic studies in the Indole series. Preparation of the unique antibiotic alkaloid chuangxinmycin by a nitro group displacement reaction. J. Am. Chem. Soc. 104(26), 7622–7626 (1982).
    • 8. Ishibashi H, Tabata T, Hanaoka K, Iriyama H, Akamatsu S, Ikeda M. A new, general entry to 4-substituted indoles. Synthesis of (S)-(-)-pindolo and (±)-chuangxinmycin. Tetrahedron Lett. 34(3), 489–492 (1993).
    • 9. Kato K, Ono M, Akita H. New total synthesis of (±)-, (−)-, (+)-chuangxinmycins. Terrahedron 57, 10055–10062 (2001).
    • 10. Su SH, Tu JD, Zhang SW. Synthesis of chuangxinmycin analogues. Chin. J. Pharm. 139(2), 17–21 (1984). • Very important report regarding the structure–activity relationship of chuangxinmycin.
    • 11. Matsumoto M, Watanabe N. Synthesis of chuangxinmycin analogues. Heterocycles 26(7), 1743–1746 (1987). • Very important report regarding the structure–activity relationship of chuangxinmycin.
    • 12. Liu ZY, Zhu JT, Jin J, Li ZR. Synthesis and antibacterial activity evaluation of chuangxinmycin prodrugs. Chin. Med. Biotechnol. 11(4), 314–318 (2016).
    • 13. Pennington LD, Moustakas DT. The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization. J. Med. Chem. 60(9), 3552–3579 (2017). •• Very important report regarding the design strategy of derivatives of chuangxinmycin.
    • 14. Richter MF, Drown BS, Riley AP et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545(7654), 299–304 (2017). •• Very important report regarding the design strategy of derivatives of chuangxinmycin.
    • 15. Guo XL, Zhang ZP. A new total synthesis of chuangxinmycin and the study of its stereoisomers. Acta Pharmaceutica Sinica 22(9), 671–678 (1987).